Skip to main content
Free research Free research Free assay review with research home and workspace preview
Quick search ChEMBL 36
Assay Detail

CHEMBL4199987

Review assay metadata, readout intent, target linkage, and publication context from the same page.

Functional
Antiproliferative activity against human A2058 cells harboring BRAF V600E/D mutant measured after 4 days
1
Total Activities
1
Compounds Tested
1
Activity Types
0
Assay Parameters

Assay Information

Assay Type Functional
Organism Homo sapiens
Cell Type A2058
Confidence 1 — Organism
Curated By Intermediate

Target

A2058 (CHEMBL613503)
Type CELL-LINE
Organism Homo sapiens

Publication

MK-8353: Discovery of an Orally Bioavailable Dual Mechanism ERK Inhibitor for Oncology.
Boga SB, Deng Y, Zhu L, Nan Y, Cooper AB, Shipps GW, Doll R, Shih NY, Zhu H, Sun R, Wang T, Paliwal S, Tsui HC, Gao X, Yao X, Desai J, Wang J, Alhassan AB, Kelly J, Patel M, Muppalla K, Gudipati S, Zhang LK, Buevich A, Hesk D, Carr D, Dayananth P, Black S, Mei H, Cox K, Sherborne B, Hruza AW, Xiao L, Jin W, Long B, Liu G, Taylor SA, Kirschmeier P, Windsor WT, Bishop R, Samatar AA.
ACS Med Chem Lett (2018) 9 : 761 -767
PubMed 30034615 · DOI

Activity Statistics

Type Count Avg pChEMBL Best pChEMBL
IC50 1 6.43 6.43

Compounds Tested

Compound Name Phase Activities Best pChEMBL
CHEMBL4213970 MK-8353 1.0 1 6.43

Activity Data

Compound Name Type Rel. Value Units pChEMBL
CHEMBL4213970 MK-8353 IC50 = 371.0 nM 6.43